Insider · CIK 0001730866

Calhoun Lesley Ann

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001730866

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2026-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	16,500
2026-03-09	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+37.5K sh	—	—	37,485
2025-07-16	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+40.2K sh	—	—	40,185
2025-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+6,250 sh	—	—	12,500
2025-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2025-02-28	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+47.3K sh	—	—	47,271
2024-09-04	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+10.9K sh	—	—	10,880
2024-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+6,250 sh	—	—	11,250
2024-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2024-06-05	TNGXTango Therapeutics, Inc.S Sale	Director	SSale	+5,000 sh	$7.21	+$36K	6,250
2024-03-01	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+309K sh	—	—	308,940
2024-02-28	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+75K sh	—	—	74,998
2024-02-28	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+51.8K sh	—	—	51,833
2024-02-28	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+18.8K sh	—	—	18,750
2024-02-27	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.3K sh	—	—	0
2024-02-27	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−176K sh	—	—	0
2024-02-27	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−105K sh	—	—	0
2023-09-08	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+48K sh	—	—	48,000
2023-06-06	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-06	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-03-15	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+78.8K sh	—	—	78,750
2022-07-07	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+52.5K sh	—	—	52,500
2022-06-08	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-02-04	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+105K sh	—	—	105,000
2022-02-04	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+26.3K sh	—	—	26,250
2020-12-01	ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+176K sh	—	—	176,237
2020-05-26	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,700 sh	—	—	900
2020-05-26	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−2,700 sh	$70.10	−$189K	154
2020-05-26	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,700 sh	$29.75	+$80.3K	2,854
2020-05-18	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−23.3K sh	$74.67	−$1.74M	154
2020-05-18	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+23.3K sh	$22.00	+$513K	23,484
2020-05-18	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−23.3K sh	—	—	1,875
2020-05-12	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−2,992 sh	$78.38	−$235K	154
2020-05-11	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−381 sh	$77.05	−$29.4K	3,146
2020-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−300 sh	—	—	600
2020-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+300 sh	—	—	3,631
2020-03-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−104 sh	$63.96	−$6,651.84	3,527
2020-02-03	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+9,160 sh	—	—	9,160
2020-02-03	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+14.6K sh	—	—	14,610
2020-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,313 sh	—	—	13,875
2020-02-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−1,154 sh	$65.26	−$75.3K	3,331
2020-02-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+3,063 sh	—	—	4,485
2020-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−750 sh	—	—	3,000
2020-01-31	Global Blood Therapeutics, Inc.A Award	See Remarks	AAward	+535 sh	$36.68	+$19.6K	1,422
2019-09-11	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−2,765 sh	$54.36	−$150K	887
2019-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−300 sh	—	—	900
2019-09-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−104 sh	$45.98	−$4,781.92	3,652
2019-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+300 sh	—	—	3,756
2019-08-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−1,060 sh	$54.25	−$57.5K	3,456

Recent filings

Accepted (ET)
Jun 84
Calhoun Lesley Ann0001193125-26-262205
SEC(opens sec.gov)
Mar 114
Calhoun Lesley Ann0001610717-26-000093
SEC(opens sec.gov)
Jul 184
Calhoun Lesley Ann0001610717-25-000286
SEC(opens sec.gov)
Jun 94
Calhoun Lesley Ann0000950170-25-083911
SEC(opens sec.gov)
Mar 44
Calhoun Lesley Ann0001610717-25-000044
SEC(opens sec.gov)
Sep 64
Calhoun Lesley Ann0001610717-24-000466
SEC(opens sec.gov)
Jun 74
Calhoun Lesley Ann0000950170-24-070875
SEC(opens sec.gov)
Mar 44
Calhoun Lesley Ann0001610717-24-000123
SEC(opens sec.gov)
Feb 284
Calhoun Lesley Ann0001610717-24-000099
SEC(opens sec.gov)
Sep 124
Calhoun Lesley Ann0001610717-23-000276
SEC(opens sec.gov)
Jun 84
Calhoun Lesley Ann0000899243-23-015019
SEC(opens sec.gov)

Companies

Address

C/O TANGO THERAPEUTICS, INC., 201 BROOKLINE AVE., SUITE 901

BOSTON, MA, 02215